Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_assertion type Assertion NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_head.
- NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_assertion description "[Four of the 10 genes with the greatest differences in expression between patients and controls, S100A8 and S100A7 (upregulated), and loricrin and filaggrin (downregulated), were epidermal differentiation genes located on 1q21, a locus previously reported to have a genetic linkage with AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_provenance.
- NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_assertion evidence source_evidence_literature NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_provenance.
- NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_assertion SIO_000772 15656815 NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_provenance.
- NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_assertion wasDerivedFrom befree-2016 NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_provenance.
- NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_assertion wasGeneratedBy ECO_0000203 NP476711.RA5GPJVntOTE6x1FVXQPAsSprZxt89CRnM8J-Q-8c7jyY130_provenance.